Pharma & Healthcare
Global Dasatinib Tablets Market Research Report 2026
- Mar 17, 26
- ID: 737733
- Pages: 96
- Figures: 95
- Views: 7
This report delivers a comprehensive overview of the global Dasatinib Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Dasatinib Tablets. The Dasatinib Tablets market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Dasatinib Tablets market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Dasatinib Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Bristol-Myers Squibb Pharma EEIG
LUCIUS Pharma
Segment by Type
50mg
200mg
300mg
400mg
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Dasatinib Tablets companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Dasatinib Tablets market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Dasatinib Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Bristol-Myers Squibb Pharma EEIG
LUCIUS Pharma
Segment by Type
50mg
200mg
300mg
400mg
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Dasatinib Tablets companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dasatinib Tablets Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 50mg
1.2.3 200mg
1.2.4 300mg
1.2.5 400mg
1.3 Market by Application
1.3.1 Global Dasatinib Tablets Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dasatinib Tablets Market Perspective (2021–2032)
2.2 Global Dasatinib Tablets Growth Trends by Region
2.2.1 Global Dasatinib Tablets Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Dasatinib Tablets Historic Market Size by Region (2021–2026)
2.2.3 Dasatinib Tablets Forecasted Market Size by Region (2027–2032)
2.3 Dasatinib Tablets Market Dynamics
2.3.1 Dasatinib Tablets Industry Trends
2.3.2 Dasatinib Tablets Market Drivers
2.3.3 Dasatinib Tablets Market Challenges
2.3.4 Dasatinib Tablets Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dasatinib Tablets Players by Revenue
3.1.1 Global Top Dasatinib Tablets Players by Revenue (2021–2026)
3.1.2 Global Dasatinib Tablets Revenue Market Share by Players (2021–2026)
3.2 Global Top Dasatinib Tablets Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Dasatinib Tablets Revenue
3.4 Global Dasatinib Tablets Market Concentration Ratio
3.4.1 Global Dasatinib Tablets Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dasatinib Tablets Revenue in 2025
3.5 Global Key Players of Dasatinib Tablets Head Offices and Areas Served
3.6 Global Key Players of Dasatinib Tablets, Products and Applications
3.7 Global Key Players of Dasatinib Tablets, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Dasatinib Tablets Breakdown Data by Type
4.1 Global Dasatinib Tablets Historic Market Size by Type (2021–2026)
4.2 Global Dasatinib Tablets Forecasted Market Size by Type (2027–2032)
5 Dasatinib Tablets Breakdown Data by Application
5.1 Global Dasatinib Tablets Historic Market Size by Application (2021–2026)
5.2 Global Dasatinib Tablets Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Dasatinib Tablets Market Size (2021–2032)
6.2 North America Dasatinib Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Dasatinib Tablets Market Size by Country (2021–2026)
6.4 North America Dasatinib Tablets Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dasatinib Tablets Market Size (2021–2032)
7.2 Europe Dasatinib Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Dasatinib Tablets Market Size by Country (2021–2026)
7.4 Europe Dasatinib Tablets Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Dasatinib Tablets Market Size (2021–2032)
8.2 Asia-Pacific Dasatinib Tablets Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Dasatinib Tablets Market Size by Region (2021–2026)
8.4 Asia-Pacific Dasatinib Tablets Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Dasatinib Tablets Market Size (2021–2032)
9.2 Latin America Dasatinib Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Dasatinib Tablets Market Size by Country (2021–2026)
9.4 Latin America Dasatinib Tablets Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dasatinib Tablets Market Size (2021–2032)
10.2 Middle East & Africa Dasatinib Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Dasatinib Tablets Market Size by Country (2021–2026)
10.4 Middle East & Africa Dasatinib Tablets Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb Pharma EEIG
11.1.1 Bristol-Myers Squibb Pharma EEIG Company Details
11.1.2 Bristol-Myers Squibb Pharma EEIG Business Overview
11.1.3 Bristol-Myers Squibb Pharma EEIG Dasatinib Tablets Introduction
11.1.4 Bristol-Myers Squibb Pharma EEIG Revenue in Dasatinib Tablets Business (2021–2026)
11.1.5 Bristol-Myers Squibb Pharma EEIG Recent Development
11.2 LUCIUS Pharma
11.2.1 LUCIUS Pharma Company Details
11.2.2 LUCIUS Pharma Business Overview
11.2.3 LUCIUS Pharma Dasatinib Tablets Introduction
11.2.4 LUCIUS Pharma Revenue in Dasatinib Tablets Business (2021–2026)
11.2.5 LUCIUS Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dasatinib Tablets Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 50mg
1.2.3 200mg
1.2.4 300mg
1.2.5 400mg
1.3 Market by Application
1.3.1 Global Dasatinib Tablets Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dasatinib Tablets Market Perspective (2021–2032)
2.2 Global Dasatinib Tablets Growth Trends by Region
2.2.1 Global Dasatinib Tablets Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Dasatinib Tablets Historic Market Size by Region (2021–2026)
2.2.3 Dasatinib Tablets Forecasted Market Size by Region (2027–2032)
2.3 Dasatinib Tablets Market Dynamics
2.3.1 Dasatinib Tablets Industry Trends
2.3.2 Dasatinib Tablets Market Drivers
2.3.3 Dasatinib Tablets Market Challenges
2.3.4 Dasatinib Tablets Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dasatinib Tablets Players by Revenue
3.1.1 Global Top Dasatinib Tablets Players by Revenue (2021–2026)
3.1.2 Global Dasatinib Tablets Revenue Market Share by Players (2021–2026)
3.2 Global Top Dasatinib Tablets Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Dasatinib Tablets Revenue
3.4 Global Dasatinib Tablets Market Concentration Ratio
3.4.1 Global Dasatinib Tablets Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dasatinib Tablets Revenue in 2025
3.5 Global Key Players of Dasatinib Tablets Head Offices and Areas Served
3.6 Global Key Players of Dasatinib Tablets, Products and Applications
3.7 Global Key Players of Dasatinib Tablets, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Dasatinib Tablets Breakdown Data by Type
4.1 Global Dasatinib Tablets Historic Market Size by Type (2021–2026)
4.2 Global Dasatinib Tablets Forecasted Market Size by Type (2027–2032)
5 Dasatinib Tablets Breakdown Data by Application
5.1 Global Dasatinib Tablets Historic Market Size by Application (2021–2026)
5.2 Global Dasatinib Tablets Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Dasatinib Tablets Market Size (2021–2032)
6.2 North America Dasatinib Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Dasatinib Tablets Market Size by Country (2021–2026)
6.4 North America Dasatinib Tablets Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dasatinib Tablets Market Size (2021–2032)
7.2 Europe Dasatinib Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Dasatinib Tablets Market Size by Country (2021–2026)
7.4 Europe Dasatinib Tablets Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Dasatinib Tablets Market Size (2021–2032)
8.2 Asia-Pacific Dasatinib Tablets Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Dasatinib Tablets Market Size by Region (2021–2026)
8.4 Asia-Pacific Dasatinib Tablets Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Dasatinib Tablets Market Size (2021–2032)
9.2 Latin America Dasatinib Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Dasatinib Tablets Market Size by Country (2021–2026)
9.4 Latin America Dasatinib Tablets Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dasatinib Tablets Market Size (2021–2032)
10.2 Middle East & Africa Dasatinib Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Dasatinib Tablets Market Size by Country (2021–2026)
10.4 Middle East & Africa Dasatinib Tablets Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb Pharma EEIG
11.1.1 Bristol-Myers Squibb Pharma EEIG Company Details
11.1.2 Bristol-Myers Squibb Pharma EEIG Business Overview
11.1.3 Bristol-Myers Squibb Pharma EEIG Dasatinib Tablets Introduction
11.1.4 Bristol-Myers Squibb Pharma EEIG Revenue in Dasatinib Tablets Business (2021–2026)
11.1.5 Bristol-Myers Squibb Pharma EEIG Recent Development
11.2 LUCIUS Pharma
11.2.1 LUCIUS Pharma Company Details
11.2.2 LUCIUS Pharma Business Overview
11.2.3 LUCIUS Pharma Dasatinib Tablets Introduction
11.2.4 LUCIUS Pharma Revenue in Dasatinib Tablets Business (2021–2026)
11.2.5 LUCIUS Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Dasatinib Tablets Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of 50mg
Table 3. Key Players of 200mg
Table 4. Key Players of 300mg
Table 5. Key Players of 400mg
Table 6. Global Dasatinib Tablets Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Dasatinib Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Dasatinib Tablets Market Size by Region (US$ Million), 2021–2026
Table 9. Global Dasatinib Tablets Market Share by Region (2021–2026)
Table 10. Global Dasatinib Tablets Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Dasatinib Tablets Market Share by Region (2027–2032)
Table 12. Dasatinib Tablets Market Trends
Table 13. Dasatinib Tablets Market Drivers
Table 14. Dasatinib Tablets Market Challenges
Table 15. Dasatinib Tablets Market Restraints
Table 16. Global Dasatinib Tablets Revenue by Players (US$ Million), 2021–2026
Table 17. Global Dasatinib Tablets Market Share by Players (2021–2026)
Table 18. Global Top Dasatinib Tablets Players by Tier (Tier 1, Tier 2, and Tier 3), based on Dasatinib Tablets Revenue, 2025
Table 19. Ranking of Global Top Dasatinib Tablets Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Dasatinib Tablets Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Dasatinib Tablets, Headquarters and Area Served
Table 22. Global Key Players of Dasatinib Tablets, Products and Applications
Table 23. Global Key Players of Dasatinib Tablets, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Dasatinib Tablets Market Size by Type (US$ Million), 2021–2026
Table 26. Global Dasatinib Tablets Revenue Market Share by Type (2021–2026)
Table 27. Global Dasatinib Tablets Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Dasatinib Tablets Revenue Market Share by Type (2027–2032)
Table 29. Global Dasatinib Tablets Market Size by Application (US$ Million), 2021–2026
Table 30. Global Dasatinib Tablets Revenue Market Share by Application (2021–2026)
Table 31. Global Dasatinib Tablets Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Dasatinib Tablets Revenue Market Share by Application (2027–2032)
Table 33. North America Dasatinib Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Dasatinib Tablets Market Size by Country (US$ Million), 2021–2026
Table 35. North America Dasatinib Tablets Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Dasatinib Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Dasatinib Tablets Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Dasatinib Tablets Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Dasatinib Tablets Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Dasatinib Tablets Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Dasatinib Tablets Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Dasatinib Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Dasatinib Tablets Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Dasatinib Tablets Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Dasatinib Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Dasatinib Tablets Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Dasatinib Tablets Market Size by Country (US$ Million), 2027–2032
Table 48. Bristol-Myers Squibb Pharma EEIG Company Details
Table 49. Bristol-Myers Squibb Pharma EEIG Business Overview
Table 50. Bristol-Myers Squibb Pharma EEIG Dasatinib Tablets Product
Table 51. Bristol-Myers Squibb Pharma EEIG Revenue in Dasatinib Tablets Business (US$ Million), 2021–2026
Table 52. Bristol-Myers Squibb Pharma EEIG Recent Development
Table 53. LUCIUS Pharma Company Details
Table 54. LUCIUS Pharma Business Overview
Table 55. LUCIUS Pharma Dasatinib Tablets Product
Table 56. LUCIUS Pharma Revenue in Dasatinib Tablets Business (US$ Million), 2021–2026
Table 57. LUCIUS Pharma Recent Development
Table 58. Research Programs/Design for This Report
Table 59. Key Data Information from Secondary Sources
Table 60. Key Data Information from Primary Sources
Table 61. Authors List of This Report
List of Figures
Figure 1. Dasatinib Tablets Picture
Figure 2. Global Dasatinib Tablets Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Dasatinib Tablets Market Share by Type: 2025 vs 2032
Figure 4. 50mg Features
Figure 5. 200mg Features
Figure 6. 300mg Features
Figure 7. 400mg Features
Figure 8. Global Dasatinib Tablets Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Dasatinib Tablets Market Share by Application: 2025 vs 2032
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Dasatinib Tablets Report Years Considered
Figure 14. Global Dasatinib Tablets Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Dasatinib Tablets Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Dasatinib Tablets Market Share by Region: 2025 vs 2032
Figure 17. Global Dasatinib Tablets Market Share by Players in 2025
Figure 18. Global Dasatinib Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Dasatinib Tablets Revenue in 2025
Figure 20. North America Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Dasatinib Tablets Market Share by Country (2021–2032)
Figure 22. United States Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Dasatinib Tablets Market Share by Country (2021–2032)
Figure 26. Germany Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Dasatinib Tablets Market Share by Region (2021–2032)
Figure 34. China Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Dasatinib Tablets Market Share by Country (2021–2032)
Figure 42. Mexico Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Dasatinib Tablets Market Share by Country (2021–2032)
Figure 46. Israel Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Bristol-Myers Squibb Pharma EEIG Revenue Growth Rate in Dasatinib Tablets Business (2021–2026)
Figure 50. LUCIUS Pharma Revenue Growth Rate in Dasatinib Tablets Business (2021–2026)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Table 1. Global Dasatinib Tablets Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of 50mg
Table 3. Key Players of 200mg
Table 4. Key Players of 300mg
Table 5. Key Players of 400mg
Table 6. Global Dasatinib Tablets Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Dasatinib Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Dasatinib Tablets Market Size by Region (US$ Million), 2021–2026
Table 9. Global Dasatinib Tablets Market Share by Region (2021–2026)
Table 10. Global Dasatinib Tablets Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Dasatinib Tablets Market Share by Region (2027–2032)
Table 12. Dasatinib Tablets Market Trends
Table 13. Dasatinib Tablets Market Drivers
Table 14. Dasatinib Tablets Market Challenges
Table 15. Dasatinib Tablets Market Restraints
Table 16. Global Dasatinib Tablets Revenue by Players (US$ Million), 2021–2026
Table 17. Global Dasatinib Tablets Market Share by Players (2021–2026)
Table 18. Global Top Dasatinib Tablets Players by Tier (Tier 1, Tier 2, and Tier 3), based on Dasatinib Tablets Revenue, 2025
Table 19. Ranking of Global Top Dasatinib Tablets Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Dasatinib Tablets Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Dasatinib Tablets, Headquarters and Area Served
Table 22. Global Key Players of Dasatinib Tablets, Products and Applications
Table 23. Global Key Players of Dasatinib Tablets, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Dasatinib Tablets Market Size by Type (US$ Million), 2021–2026
Table 26. Global Dasatinib Tablets Revenue Market Share by Type (2021–2026)
Table 27. Global Dasatinib Tablets Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Dasatinib Tablets Revenue Market Share by Type (2027–2032)
Table 29. Global Dasatinib Tablets Market Size by Application (US$ Million), 2021–2026
Table 30. Global Dasatinib Tablets Revenue Market Share by Application (2021–2026)
Table 31. Global Dasatinib Tablets Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Dasatinib Tablets Revenue Market Share by Application (2027–2032)
Table 33. North America Dasatinib Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Dasatinib Tablets Market Size by Country (US$ Million), 2021–2026
Table 35. North America Dasatinib Tablets Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Dasatinib Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Dasatinib Tablets Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Dasatinib Tablets Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Dasatinib Tablets Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Dasatinib Tablets Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Dasatinib Tablets Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Dasatinib Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Dasatinib Tablets Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Dasatinib Tablets Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Dasatinib Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Dasatinib Tablets Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Dasatinib Tablets Market Size by Country (US$ Million), 2027–2032
Table 48. Bristol-Myers Squibb Pharma EEIG Company Details
Table 49. Bristol-Myers Squibb Pharma EEIG Business Overview
Table 50. Bristol-Myers Squibb Pharma EEIG Dasatinib Tablets Product
Table 51. Bristol-Myers Squibb Pharma EEIG Revenue in Dasatinib Tablets Business (US$ Million), 2021–2026
Table 52. Bristol-Myers Squibb Pharma EEIG Recent Development
Table 53. LUCIUS Pharma Company Details
Table 54. LUCIUS Pharma Business Overview
Table 55. LUCIUS Pharma Dasatinib Tablets Product
Table 56. LUCIUS Pharma Revenue in Dasatinib Tablets Business (US$ Million), 2021–2026
Table 57. LUCIUS Pharma Recent Development
Table 58. Research Programs/Design for This Report
Table 59. Key Data Information from Secondary Sources
Table 60. Key Data Information from Primary Sources
Table 61. Authors List of This Report
List of Figures
Figure 1. Dasatinib Tablets Picture
Figure 2. Global Dasatinib Tablets Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Dasatinib Tablets Market Share by Type: 2025 vs 2032
Figure 4. 50mg Features
Figure 5. 200mg Features
Figure 6. 300mg Features
Figure 7. 400mg Features
Figure 8. Global Dasatinib Tablets Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Dasatinib Tablets Market Share by Application: 2025 vs 2032
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Dasatinib Tablets Report Years Considered
Figure 14. Global Dasatinib Tablets Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Dasatinib Tablets Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Dasatinib Tablets Market Share by Region: 2025 vs 2032
Figure 17. Global Dasatinib Tablets Market Share by Players in 2025
Figure 18. Global Dasatinib Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Dasatinib Tablets Revenue in 2025
Figure 20. North America Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Dasatinib Tablets Market Share by Country (2021–2032)
Figure 22. United States Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Dasatinib Tablets Market Share by Country (2021–2032)
Figure 26. Germany Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Dasatinib Tablets Market Share by Region (2021–2032)
Figure 34. China Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Dasatinib Tablets Market Share by Country (2021–2032)
Figure 42. Mexico Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Dasatinib Tablets Market Share by Country (2021–2032)
Figure 46. Israel Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Dasatinib Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Bristol-Myers Squibb Pharma EEIG Revenue Growth Rate in Dasatinib Tablets Business (2021–2026)
Figure 50. LUCIUS Pharma Revenue Growth Rate in Dasatinib Tablets Business (2021–2026)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232